首页 | 本学科首页   官方微博 | 高级检索  
     

血必净注射液与头孢哌酮钠/舒巴坦钠协同治疗脓毒症的临床观察
引用本文:蔡绚,蔡涛,虞晓红. 血必净注射液与头孢哌酮钠/舒巴坦钠协同治疗脓毒症的临床观察[J]. 中国药房, 2008, 19(20): 1563-1564
作者姓名:蔡绚  蔡涛  虞晓红
作者单位:1. 贵阳医学院附属医院,贵阳市,550004
2. 贵阳市第二人民医院,贵阳市,550001
摘    要:目的:观察和评价血必净注射液与注射用头孢哌酮钠/舒巴坦钠协同治疗脓毒症的临床疗效。方法:随机将脓毒症患者分为对照组(75例)与治疗组(79例)。对照组静脉滴注头孢哌酮钠/舒巴坦钠3g,每日2次;治疗组先静脉滴注头孢哌酮钠/舒巴坦钠3g,再静脉滴注血必净注射液100mL,每日2次。7d为1个疗程。结果:治疗组与对照组总有效率分别为94.94%、86.67%,2组有显著性差异(P<0.05)。结论:血必净注射液与头孢哌酮钠/舒巴坦钠协同治疗脓毒症,能够缩短疗程,改善临床症状,提高疗效。

关 键 词:血必净注射液  头孢哌酮钠/舒巴坦钠  脓毒症  协同作用

Synergetic Effect of Xuebijing Injection and Cefoperazone Sodium/Sulbactam Sodium on Sepsis
CAI Xuan,CAI Tao,YU Xiao-hong. Synergetic Effect of Xuebijing Injection and Cefoperazone Sodium/Sulbactam Sodium on Sepsis[J]. China Pharmacy, 2008, 19(20): 1563-1564
Authors:CAI Xuan  CAI Tao  YU Xiao-hong
Affiliation:CAI Xuan, CAI Tao,YU Xiao-hong(The Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China;The 2nd People's Hospital of Guiyang, Guiyang 550001, China)
Abstract:OBJECTIVE: To observe the synergetic effect of Xuebijing injection and Cefoperazone Sodium/ Sulbactam Sodium for the treatment of patients with sepsis. METHODS: Patients with sepsis were randomly assigned to receive Cefoperazone Sodium/Sulbactam Sodium 3 g bid alone by iv drip (Control Group, 75 cases) or in combination with Xuebijing injection (100 mL bid, 79 cases) for 7 days. RESULTS: The total efficective rate after 7-day treatment had significant difference between two groups (86.67% in control group versus 94.94% in treatment group, (P 〈0.05) . CONCLUSION: The addition of Xuebijing injection to Cefoperazone Sodium/ Sulbactam Sodium significantly reduced the course of treatment for the sepsis disease, improved clinical symptoms and increased the curative effect.
Keywords:Xuebijing injection  Cefoperazone sodium/sulbactam sodium  Sepsis  Synergetic effect
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号